FRANK MCCORMICK
CIK 1257809 · Chairman of Oncology · last filed 2026-06-24
FRANK MCCORMICK is a Chairman of Oncology who has filed 37 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for BBIO, was dated Jun 24, 2026. Across all open-market trades the lifetime net is −$33.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $68.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$68.84M
5
37
-$33.91M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBIO | Director | 767,244 | $85.55 | $65.64M | -$33.91M | 16 | 2026-06-24 |
| BBOT | Director | — | $8.59 | — | $0 | 2 | 2026-06-18 |
| OLMA | Director | 275,373 | $11.62 | $3.20M | $0 | 2 | 2020-11-23 |
| CHINOOK THERAPEUTICS, INC. (ADRO) Delisted | Director | — | — | — | $0 | 4 | 2018-06-08 |
| EXEL | Director | — | $56.51 | — | $0 | 8 | 2013-12-09 |
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-24 | BBIO | Grant (A) | +3,990 | $0 | EDGAR |
| 2026-06-18 | BBOT | Grant (A) | — | $0 | EDGAR |
| 2025-10-31 | BBIO | Sell (S) | −198,359 | -$13.21M | EDGAR |
| 2025-10-29 | BBIO | Notice (144) | −198,359 | -$13.21M | EDGAR |
| 2025-10-29 | BBIO | Sell (S) | −1,641 | -$106.7K | EDGAR |
| 2025-10-27 | BBIO | Notice (144) | −1,641 | -$106.7K | EDGAR |
| 2025-09-08 | BBIO | Mixed | — | -$3.05M | EDGAR |
| 2025-09-05 | BBIO | Notice (144) | −74,000 | -$3.93M | EDGAR |
| 2025-08-28 | BBOT | Grant (A) | — | $0 | EDGAR |
| 2025-06-26 | BBIO | Sell (S) | −100,000 | -$4.42M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.